Results 181 to 190 of about 34,531 (209)
Some of the next articles are maybe not open access.
21-hydroxylase deficiency congenital adrenal hyperplasia
The Journal of Steroid Biochemistry and Molecular Biology, 1994Congenital adrenal hyperplasia (CAH) results from an enzymatic block at any stage in the synthesis of cortisol. All enzyme defects causing CAH are autosomal recessive traits. It is a relatively common disease, occurring in 1 in 5000 to 1 in 15,000 births in most populations.
openaire +3 more sources
Steroid 21-hydroxylase deficiency
Current Opinion in Pediatrics, 1989Perrin C. White +2 more
openaire +2 more sources
Prenatal diagnosis of 21‐hydroxylase deficiency
Prenatal Diagnosis, 1988Cynthia Callaway +2 more
openaire +5 more sources
The Genetics of 21-Hydroxylase Deficiency
The Endocrinologist, 1994Phyllis W. Speiser, Javier Aisenberg
openaire +2 more sources
Nonclassic 21-hydroxylase deficiency in Croatia
2003Background/Aims:This is the first report of nonclassic congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (21-OHD) in Croatia in which the patients have been evaluated clinically, hormonally, and by molecular genetic analysis. Methods: Genetic analysis were performed on 18 Croatian patients with nonclassic CAH owing to 21-hydroxylase ...
Dumić, Miroslav +7 more
openaire +2 more sources
THE MOLECULAR GENETICS OF 21-HYDROXYLASE DEFICIENCY
Annual Review of Genetics, 1989Walter L. Miller, Yves Morel
openaire +2 more sources
Kawasaki syndrome and 21‐hydroxylase deficiency
Pediatrics International, 2008Takayuki Tanabe +6 more
openaire +3 more sources
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann S De Bono
exaly